UK's CMA Goes After Advanz, Morningside And Alliance On Nitrofurantoin

 
• By Dave Wallace

The UK’s Competition and Markets Authority has issued a statement of objections to Advanz, Morningside and wholesaler Alliance Healthcare after provisionally finding that the firms broke competition law by arranging to carve up the UK market for nitrofurantoin.

CMA
The CMA Has Issued A Statement Of Objections To Three Firms • Source: Shutterstock

More from Regulation

More from Policy & Regulation